DNA Sensing in Mismatch Repair-Deficient Tumor Cells Is Essential for Anti-tumor Immunity

Lu, Changzheng, Guan, Junhong, Lu, Steve, Jin, Qihuang, Rousseau, Benoit, Lu, Tianshi, Stephens, Dennis, Zhang, Hongyi, Zhu, Jiankun, Yang, Mingming, Ren, Zhenhua, Liang, Yong, Liu, Zhida, Han, Chuanhui, Liu, Longchao, Cao, Xuezhi, Zhang, Anli, Qiao, Jian, Batten, Kimberly, Chen, Mingyi, Castrillon, Diego H., Wang, Tao, Li, Bo, Diaz, Luis A., Li, Guo-Min, Fu, Yang-Xin·2021·Cancer Cell

DOI 10.1016/j.ccell.2020.11.006

Cited by (285)

Items 201–285 of 285

cGAS and STING in Host Myeloid Cells Are Essential for Effective Cyclophosphamide Treatment of Advanced Breast Cancer
Yein‐Gei Lai, Hao-Ting Liao, Yung‐Hsiang Chen, Shih‐Wen Huang, Yae-Huei Liou, Zhenqi Wu, Nan‐Shih Liao · 2025 · Cancers
DNA repair at the crossroads of tumor immunogenicity and cancer therapy: Harnessing innate and adaptive immune pathways for improved therapeutic outcomes
Zhanfeng Liang, Yangrui Xu, Chuan‐Yuan Li · 2025 · DNA repair
The mismatch recognition protein MutSα promotes nascent strand degradation at stalled replication forks
Junqiu Zhang, Xin Zhao, Lu Liu, Hao‐Dong Li, Liya Gu, Diego H. Castrillón, Guo‐Min Li · 2022 · Proceedings of the National Academy of Sciences
The cyclic guanosine monophosphate synthase-stimulator of interferon genes pathway as a potential target for tumor immunotherapy
Rui Chen, Mingxia Liu, Quanhong Jiang, Xiangbo Meng, Junmin Wei · 2023 · Frontiers in Immunology
Dissecting Response and Resistance to Anti–PD-1 Therapy in Microsatellite-Unstable Gastric Cancer
Elisa Fontana, Elizabeth Catherine Smyth · 2021 · Cancer Discovery
Construction and Evaluation of Clinical Prediction Model for Immunotherapy-related Adverse Events and Clinical Benefit in Cancer Patients Receiving Immune Checkpoint Inhibitors Based on Serum Cytokine Levels
Ni Zhao, Aimin Jiang, Xiao Shang, Fumei Zhao, Ruoxuan Wang, Xiao Fu, Zhiping Ruan, Xuan Liang, Tao Tian, Yu Yao et al. · 2023 · Journal of Immunotherapy
The clathrin adaptor AP1-S1 is associated with immune infiltration and HLA loss, as a potential therapeutic target in lung adenocarcinoma
Yafei Liu, Feng Li, Bin Wu, Lan Huang, Yu Qi · 2025 · International Immunopharmacology
SITC strategic vision: prevention, premalignant immunity, host and environmental factors
Sasha Elizabeth Stanton, Kristin G. Anderson, Tullia Carmela Bruno, Christian M. Capitini, Mary Lenora Disis, Jennifer Leigh McQuade, Laszlo George Radvanyi, Claire Vanpouille‐Box, Jennifer Ann Wargo, Kelly J. Baines et al. · 2025 · Journal for ImmunoTherapy of Cancer
ISGylation prevents autophagic degradation of STING and promotes antitumor immunity in lung cancer
Dan Cao, Huang Bin, Xinming Fu, Ming Liu, Xiaogang Niu, Hongbin Zhai, Hao Huang · 2026 · Cell Death and Disease
Recent Research Advances in Double-Strand Break and Mismatch Repair Defects in Prostate Cancer and Potential Clinical Applications
Damian Jaworski, Bartosz Brzoszczyk, Łukasz Szylberg · 2023 · Cells
DNA mismatch repair system regulates the expression of PD-L1 through DNMTs in cervical cancer
Fan Guo, Ruijiao Lu, Weina Kong, Miyessar Anwar, Yangchun Feng · 2024 · Cancer Cell International
Innate immune sensing of macromolecule homeostasis
Kun Yang, Devon Jeltema, Nan Yan · 2024 · Advances in immunology
Advances in Radiotherapy Immune Modulation
Charles X. Wang, Jared Hunt, Shera Feinstein, Soo Kyoung Kim, Arta Monir Monjazeb · 2023 · Surgical Oncology Clinics of North America
Prognostic value of tumor mutation burden in patients with advanced gastric cancer receiving first-line chemotherapy
Xiao-Peng Duan, Ke Liu, Xiao‐Dong Jiao, Bao‐Dong Qin, Bing Li, Xi He, Yan Ling, Ying Wu, Shiqi Chen, Yuan‐Sheng Zang · 2023 · Frontiers in Oncology
Predicting response to immune checkpoint blockade therapy among mismatch repair-deficient patients using mutational signatures
D. Gulhan, Vinay Viswanadham, Francesc Muyas, Hu Jin, Michael Bonner Foote, Jake June-Koo Lee, David Barras, Youngsook Lucy Jung, Viktor Ljungström, Benoı̂t Rousseau et al. · 2024 · medRxiv
Pyrithione zinc alters mismatch repair to trigger tumor immunogenicity
Huanling Zhang, Jiaxin Wu, Lei Cui, Tiantian Wang, Huan Jin, Hui Guo, Chunyuan Xie, Lin Li, Xiaojuan Wang, Zining Wang · 2025 · Oncogene
Computed tomography radiomics to predict microsatellite instability status and immunotherapy response in gastric cancer
Zhou Li, Zixuan Ding, Yongping Lian, Yongqing Liu, Lei Wang, Pengbo Hu, Fangyuan Zhang, Yan Luo, Hong Xia Qiu · 2025 · Insights into Imaging
Innate immunity in tumour immunoediting and immunosurveillance
Zhibin Zhang, Ying Zhang, Judy Lieberman · 2025 · The EMBO Journal
Targeting DNA damage response to enhance cancer immunotherapy efficacy: molecular mechanisms and clinical advances
Ziyi Tang, Pan Chen, Bo Xiang, Wei Xiong, Pan Wu, Zhaoyang Zeng · 2025 · Medical Oncology
Comprehensive prognostic and immunological analysis of Cullin2 in pan-cancer and its identification in hepatocellular carcinoma
Longmei Jia, Xiaoqiang Zhang, Tao Zhou, Jinyan Xie, Jiejing Jin, Dandan Zhang, Chao Zhu, Rong Wan · 2024 · Aging
SET facilitates immune escape of microsatellite stability colorectal cancer by inhibiting c‐Myc degradation
Liping Gao, Yizhang Li, Haizhou Wang, Jialong Liu, Ranran Zhang, Wenqing Shan, Lingxiu Zeng, Qiu Zhao, Yong Li, Jing Liu · 2024 · Cancer Science
Molecular subtypes of cuproptosis regulators and their correlation with clinical prognosis and immune response in glioma.
Yan Zhang, Xuehui Dai, Zhanzhan Li · 2022 · PubMed Central
MutS and MutL sliding clamps in DNA mismatch repair
Xiao-Peng Han, Xiaowen Yang, Jiaquan Liu · 2022 · Genome Instability & Disease
EBV enhances immunotherapy sensitivity in intrahepatic cholangiocarcinoma through cGAS-STING pathway activation
Lingli Huang, Qian Zhong, Silan Huang, Kejia Yang, Yuchen Cai, Guifang Guo · 2025 · Hepatology Communications
cGAS/STING signalling in macrophages aggravates obliterative bronchiolitis via an IFN‐α‐dependent mechanism after orthotopic tracheal transplantation in mice
Junhao Wan, Hao Liu, Chuangyan Wu, Ting Zhou, Fengjing Yang, Xiaoyue Xiao, Song Tong, Sihua Wang · 2025 · Clinical and Translational Medicine
Predicting Microsatellite Instability in Endometrial Cancer by Multimodal Magnetic Resonance Radiomics Combined with Clinical Factors
Qiu-ying Wei, Yi Li, Xiaoli Huang, Yuchen Wei, Chong-ze Yang, Yanyan Yu, Jin-yuan Liao · 2025 · Academic Radiology
Molecular classification of microsatellite-instable colorectal cancers reveals distinct predictors of immunotherapy response
Cong Lin, Tao Luo, Meng Yin Wu, Fuqiang Li, Luís Nunes, Artur Mezheyeuski, Klara Hammarström, Anders Isaksson, Ingrid Ljuslinder, Mathias Uhlén et al. · 2025 · ESMO Gastrointestinal Oncology
Bafetinib enhances anti-tumor immunity by activating the NLRP3 inflammasome in macrophage
Didi Liu, Xiangyu Jin, Yao Zeng, Xinru Zhou, Minyu Wang, Hui Shen, Yi Huang · 2026 · Autophagy
Divergent Roles of Canonical and Non-Canonical Mismatch Repair in Regulating Temozolomide Sensitivity in Glioblastoma
Shiv Kumar Gupta, Sonia Jain, Teddy Friedman, Jann Nagina Sarkaria · 2026 · International Journal of Molecular Sciences
The DNA damage response and cancer immunotherapy
Hong Sheng, Guo‐Min Li · 2026 · Nature reviews. Cancer
The cGAS/STING pathway in cancer: translating innate DNA sensing into therapeutic potential
Yi Wang, Juan Carlos Angulo-Lozano, Yueqi Wang, Liang Deng · 2026 · Journal of Clinical Investigation
Differentially expressed circular RNA profiles and comprehensive analysis of circRNA-miRNA-mRNA regulatory network in microsatellite instability-high endometrial cancer
Weijia Wen, Yuan Li, Xueyuan Zhao, Jia Yan, Linna Chen, Hongye Jiang, Wei Ting Wang, Chunyu Zhang, Shuzhong Yao · 2024 · Genomics
Combinatorial Strategies for T Lymphocyte-Based Cancer Immunotherapy
Kristian Michael Hargadon, James B. Wall · 2022 · Springer eBooks
Functionalization of Mesoporous Silica with a G-A-Mismatched dsDNA Chain for Efficient Identification and Selective Capturing of the MutY Protein
Jingqi Sun, Jianhua Wang, Xuwei Chen · 2023 · ACS Applied Materials & Interfaces
Genetic and immune landscape evolution defines subtypes of MMR deficient colorectal cancer
Benjamin R. Challoner, Andrew Woolston, David K. Lau, Marta Buzzetti, Caroline Fong, Louise J. Barber, Gayathri Anandappa, Richard Crux, Ioannis Assiotis, Kerry Fenwick et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
UBE2N as a novel prognostic and therapeutic biomarker of lung adenocarcinoma
Haofeng Yin, Yibo Xue, Chen Wang, Yanqin Wu, Yuchen Guo, Chunzhen Li, Yunyan Zhang, Shulei Yin, Tiejun Zhao · 2025 · Frontiers in Immunology
Immune evasion in endometrial cancer: Unraveling the latest mechanisms and future directions
Ting-ting Li, Chunfeng Wang, Guang-cai Peng, Fang Zhou, Heng Zhang, Jinhong Zhou · 2025 · Critical Reviews in Oncology/Hematology
Harnessing mismatch repair deficiency for therapeutic targeting in cancers
Irem Yenidogan, Uri Y. Tabori, Anirban Das · 2025 · Expert Opinion on Therapeutic Targets
Combinatorial Strategies for T Lymphocyte-Based Cancer Immunotherapy
Kristian Michael Hargadon, James B. Wall · 2025 · Springer eBooks
PCBP1 binding to single-stranded poly-cytosine motifs enhances cGAS sensing and impairs breast cancer development
Cécile Fréreux, Joseph A. Q. Karam, Breege V. Howley, Bryan Granger, Paramita Chakraborty, Silvia G. Vaena, Martin J. Romeo, Annamarie C. Dalton, Bidyut K. Mohanty, Shikhar Mehrotra et al. · 2026 · Communications Biology
Telmisartan increases olaparib efficacy in homologous recombination proficient tumors by augmenting type I interferon production
Clare E Murray, Carlos Oscar Ontiveros, Jordan Wentworth, Paige Blinkiewicz, Bernice Leung, Haiyan Bai, Nathaniel Spicer, Anja N. Holtz, Chris Tanner, Akshaya Balasubramanian et al. · 2026 · Journal for ImmunoTherapy of Cancer
Current Status of the Diagnosis and Treatment of Mismatch Repair Deficient Colorectal Cancer
Donald J. Bastin, Vladimir Djedovic, Angela J. Hyde, Rachel A. Goodwin, Timothy R. Asmis, Michael M. Vickers · 2026 · Biomedicines
Inducing tumor-intrinsic innate immune response to break cancer immunotherapy resistance
Jessica A. Blandino, Takahiko Murayama · 2026 · Frontiers in Medicine
Tumor-draining lymph nodes shape the tumor microenvironment through enrichment of tumor-reactive effector-exhausted CD8+ T cells
Deyang Kong, Lin Feng, Y X Sun, Haitao Zhang, Jialiang Fan, Yueyi An, Yuelu Zhu, Yuelu Zhu, Qi Zhang, Renshen Xiang et al. · 2026 · Signal Transduction and Targeted Therapy
Biomarkers for predicting and monitoring the efficacy of cancer vaccines
Julia A. Remizova, Anastasia G. Volkova, Anna S. Makarova, Valentin Vladimirovich Makarov, V. G. Yudin, Anton Arturovich Keskinov · 2026 · Frontiers in Oncology
The Alteration of T-Cell Heterogeneity and PD-L1 Colocalization During dMMR Colorectal Cancer Progression Defined by Multiplex Immunohistochemistry
Hongkai Yan, Yaqi Li, Xiaoyu Wang, Juanjuan Qian, Midie Xu, Junjie Peng, Dan Huang · 2022 · Frontiers in Oncology
Research Progress of Radiotherapy Combined with Immunotherapy in Non-Small Cell Lung Cancer
泽宁王 · 2024 · Journal of Clinical Personalized Medicine
cGAS/STING and NLRP3 cooperatively activate CD8+ T cell-mediated anti-tumor immunity in colorectal cancer
Courtney Mowat, Daniel Schiller, Kristi Baker · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
Inhibition of O-GlcNAc transferase activates type I interferon-dependent antitumor immunity by bridging cGAS-STING pathway
Jianwen Chen, Bao Lu Zhao, Hong Dong, Tianliang Li, Xiang Cheng, Wang Gong, Jing Wang, Junran Zhang, Gang Xin, Yanbao Yu et al. · 2024 · eLife
Refining precision immunotherapy
Leslie K. Ferrarelli · 2021 · Science Signaling
In the literature: February 2021
Juan Miguel Cejalvo, Valentina Gambardella, Tania Fleitas, Andrès M.R. Cervantes · 2021 · ESMO Open
Acquired resistance to anti-PD1 therapy in patients with NSCLC reveals changes in T cell phenotypes and MET amplification
Stefanie Hiltbrunner, Lena Cords, Sabrina Kasser, Sandra N. Freiberger, Susanne Kreutzer, Nora C. Toussaint, Linda Grob, Isabelle Opitz, Michael Messerli, Martin Zoche et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
The identification of MITA: history and current status
Bo Zhong, Hong‐Bing Shu · 2022 · Scientia Sinica Vitae
Data from PBRM1 Deficiency Confers Synthetic Lethality to DNA Repair Inhibitors in Cancer
Roman M. Chabanon, Daphné Morel, Thomas Eychenne, Leo Colmet Daage, Ilirjana Bajrami, Nicolas Dorvault, Marlène Garrido, Cornelia Meisenberg, Andrew E. Lamb, C. Duong-Ngo et al. · 2023
A recommended testing region in MLH1 promoter for methylation detection in colorectal cancer patients
Xiaoli Tan, Yongzhen Fang, Xinjuan Fan, Weihao Deng, Jinglin Huang, Yacheng Cai, Jiaxin Zou, Zhiting Chen, Hanjie Lin, Liang Xu et al. · 2023 · Research Square
Changes in PD-L1 expression on microvessel endothelial cells during melanoma tumor growth and the regulation by anlotinib
Yingfang Feng, Yuan Gao, Tingting Qin, Yan Zhang, Shaochuan Liu, Jing Wang, Kai Li · 2023 · Research Square
Autophagy inhibition in pancreatic cancer cells synergizes with immunotherapy via DC activation due to increased antigenicity and adjuvanticity
Kohei Nakata, Koki Oyama, Chikanori Tsutsumi, Masataka Hayashi, Bo Zhang, Yuki Mochida, Tomohiko Shinkawa, Pingshan Zhong, Satomi Date, Haizhen Luo et al. · 2023 · Research Square
Inhibition of O-GlcNAc transferase activates type I interferon-dependent antitumor immunity by bridging cGAS-STING pathway
Jianwen Chen, Bao Lu Zhao, Tianliang Li, Hong Dong, Xiang Cheng, Wang Gong, Jing Wang, Junran Zhang, Gang Xin, Yanbao Yu et al. · 2024 · eLife
A conserved subset of cold tumors responsive to immune checkpoint blockade
Jade Moore, Jim Gkantalis, Inés Guix, William S. Chou, Kobe Chi Yung Yuen, Ann A. Lazar, Mathew Spitzer, Alexis J. Combes, Mary Helen Barcellos‐Hoff · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
Clinicopathological features and prognostic significance of TAF1L in gastric cancer
Han Chen, Hang Chen, Jingquan Fang, Xingmao Huang, Xiu Zhu, Tengjiao Chai, Xiangliu Chen, Ling Huang, Pengfei Yu · 2024 · BMC Gastroenterology
Interfaces Between the DNA Damage Response and Anti-cancer Immunity
Charleen Chan Wah Hak, Magnus T. Dillon · 2025 · The Cancer Journal
Genomic pathogenic alterations in the SWI/SNF complex compromise the outcomes of immunotherapy in Chinese patients with KRAS-mutant NSCLC by downregulating STING expression
Lingling Gao, Jie Jiang, Linlin Zhu, Zhi Xie, Yu Chen, Zhiyi Lv, Yuqing Chen, Wenbin Zhou, Ji Chen, Yumin Zhong et al. · 2025 · BMC Medicine
Increased immunogenicity of hypermutated SB28 syngeneic glioblastoma is partially mediated by alterations in tumor chemokine expression
Kevin Thomas Breen, Tuesday Haynes, Matthew Watowich, Seketoulie Keretsu, Aiguo Li, Yongmei Zhao, Wei Zhang, Meili Zhang, Hua Song, Nicole Briceno et al. · 2025 · Neuro-Oncology Advances
Additional file 1 of Targeting SUMOylation with an injectable nanocomposite hydrogel to optimize radiofrequency ablation therapy for hepatocellular carcinoma
Liu, Junfeng, Xi Li, Chen, Jiawen, Jingpei Guo, Guo, Hui, Xiaoting Zhang, Jinming Fan, Zhang, Ke, Mao, Junjie, Bin Zhou · 2024 · Figshare
Efficacy and mechanism of action of sovleplenib for aplastic anemia
Tianzi Sheng, Wei Sun, Shan Xin, Chengcheng Zhou, Hong Liu · 2026 · Hematology
RMI2 Depletion Recovers cGAS-STING Signaling to Enhance Immunotherapy in Colorectal Cancer
Weixiang Zhan, Runkai Cai, Enmin Huang, Yina Liu, Xiaoshuang Lyu, Yang Fu, Fan Bai, Chenxu Guo, Ge Qin, Yuqian Xie et al. · 2026 · Research Square
Targeting WIP1 reprograms immunosuppressive tumor microenvironment to potentiate immunotherapy response in colorectal cancer
Lini Chen, Miaoqin Chen, Shijin Yuan, Yanmei Wang, Hao Wang, Liyuan Zhu, Chandra Sugiarto Wijaya, Jinye Xu, Jiaying Shen, Dingwei Chen et al. · 2026 · Cell Death and Differentiation
Pioneering preoperative anti-PD-1 immunotherapy enables curative resection in dMMR advanced/recurrent endometrial carcinoma: a case series (2020–2022)
Huijiao Fu, Bo Yang, Jing Li, Xingxin Zhu, Yunjun Yang, Songhua Yuan · 2026 · Discover Oncology
Rational modulation of immune mechanisms synergizes the anti-tumor effects of targeted radiation therapy in pre-clinical models
Tristan Wirtz, Catherine Lee, Sripad Ram, Tao Xie, Sepideh Mojtahedzadeh, Nicole Streiner, Kavon Noorbehesht, Lisa K. Manzuk, Allison K. Rohner, Edward Cabral et al. · 2026 · Frontiers in Immunology
Rôle de TRIM33 dans l'immunothérapie anti-tumorale radio-induite
Anaïs Assouvie · 2021 · theses.fr (ABES)
cGAS bends unpaired DNA to form an unconventional structure that hyperactivates the innate immune response
Shuangshuang Yang, Shuai Wu, Silian Chen, Xin Li, Iryna Chelepis, Smaranda Willcox, Katherine Camille Barnett, Xiaoqing Hu, Guannan Huang, W. June Brickey et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
DNA damage response dysregulation in colorectal cancer
Bhavana Veerabhadrappa, Sudarshan Roy, Amitha Kozhiparambath, Ajeetha Lachaud, Madhu Dyavaiah · 2026 · Elsevier eBooks
Causal Effects and Single‐Cell Microenvironmental Implications of Germline Variant‐Regulated Lactylation‐Related Pro‐Oncogenic Genes in Colorectal Cancer
Biao Sheng, Jianwei Wang · 2026 · Human Mutation
Inhibiting PPM1D Perturbs Mitochondrial Integrity to Stimulate cGAS-STING Signaling and Antitumor Immunity
Li Zhang, X Zheng, Haotian Fu, Lu Liu, Wei Zhang, Y Zhang, Zhenzhen Gao, Sitong Zhang, Yitian Jin, Sheng Yan · 2026 · Cancer Research
STING Activation by Photo-immunogenic Nanophotocages for Synergistic Photoimmunotherapy of Cold Tumor
Lili Yao, Sixin Li, Xiaohe Zhang, Youkang Zhai, Jiaping Shen, Chao Deng, Wenhai Lin, Shengliang Li, Zhiyuan Zhong · 2026 · Journal of the American Chemical Society
A DR5/Ligase 3-Mediated Feedback Loop Perpetuates Immunogenicity in Mismatch Repair Deficient Colorectal Cancer
Suisui Hao, Yoshiaki Sato, Francesca Battaglin, Joanne Xiu, Yi-Jun Wang, Karam Ashouri, Darleny Y. Lizardo, Zhaojin Liu, X LU, Matthew Oberley et al. · 2026 · Gastroenterology
MR Imaging and Spectroscopy reveals metabolic changes in glioblastoma driven by treatment with temozolomide and lonidamine
Tareq Alrashidi, Sourav Bhaduri, Elisabeth Non Gash, Sharifa Alyetama, Mark R. Morgan, Marco Sciacovelli, Mohesh Moothanchery, Mahon L. Maguire, Lorenzo Ressel, Harish Poptani · 2026 · Research Square
Arginine methyltransferase PRMT3 suppresses tumor-intrinsic immunity via promoting cGAS methylation
Yu Chen, Yang Liu, Jianfeng Peng, Xiaolong Wang, Zhonghui Wei, Xiaoyan Yin, Xueying Zhai, Yankang Li, Jinming Yu, Xiangjiao Meng · 2026 · Cancer Letters
Mismatch repair protein MLH1 controls testis development by regulating the Hippo-YAP signaling pathway
Xueying Li, Jiajun Yang, Guo‐Min Li · 2026 · Nucleic Acids Research
Updates in the Molecular Biology and Personalized Management of Lynch Syndrome
David J. Lee, Matthew B.B. Yurgelun · 2026 · Gastroenterology Clinics of North America
γ-Mangostin Induces Immunogenic Cell Death and Activates cGAS Signaling in Acute Myeloid Leukemia
Krzysztof Wiśniewski, Małgorzata Nowak, Tomasz Adamczyk · 2025 · Specialty journal of Pharmacognosy Phytochemistry and Biotechnology
cGAS‑STING pathway in digestive tract cancer: From molecular mechanisms to therapeutic applications (Review)
Tangna Chen, Jingyi Zhang, Jinghan Sun, Hongyan Zhang, Deqiang Huang, Haifeng Ye · 2026 · International Journal of Oncology
TREX1 limits anti-tumor immunity by degrading short cytosolic DNA molecules
C.Y. Yang, Bayan Chami, Chiara Ursino, Silpa Mary Johnson, Julien Faget, Clément Mettling, Laurent Gros, Philippe Pasero, Yi‐Ching Lin · 2026 · EMBO Reports
Molecular Checkpoints of Nucleic Acid Sensing in Tumor Cells: Linking Innate Immune Evasion to Precision Cancer Immunotherapy
Yan Wang, Bowei Cao, Huili Lu, Zhicheng Wang, Yanli Qin · 2026 · International Journal of Molecular Sciences
Mitochondrial DNA abundance is a determinant of immunogenic cell death in cancer
Kosuke Tanaka, Yasuki Adachi, Takuma Irie, Tomoko Yamamori-Morita, Kazuhiro Kumagai, Takuya Owari, Genki Okumura, Yoshihisa Kobayashi, Hideaki Bando, Yuichiro Tsukada et al. · 2026 · Immunity